{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:21:01Z","timestamp":1648599661554},"reference-count":46,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.bbamcr.2003.12.007","type":"journal-article","created":{"date-parts":[[2004,2,7]],"date-time":"2004-02-07T10:16:00Z","timestamp":1076148960000},"page":"117-127","source":"Crossref","is-referenced-by-count":2,"title":["Tumour metabolites regulate tissue kallikrein in human umbilical vein endothelial cells"],"prefix":"10.1016","volume":"1691","author":[{"given":"S","family":"Naidoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Raidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Mahabeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2003.12.007_BIB1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.med.49.1.407","article-title":"Angiogenesis and tumour metastasis","volume":"49","author":"Zetter","year":"1998","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumour angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1357-4310(97)01167-2","article-title":"Angiogenesis: regulation and dysregulation","volume":"97","author":"Mousa","year":"1998","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0002-9440(10)64739-6","article-title":"Vasculogenic mimicry and tumor angiogenesis","volume":"156","author":"Folberg","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1005770612294","article-title":"An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action","volume":"15","author":"Gradishar","year":"1997","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1359-6446(00)01534-8","article-title":"Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitors","volume":"5","author":"Sun","year":"2000","journal-title":"DDT"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-2952(00)00529-3","article-title":"Angiogenesis: Regulators and clinical applications","volume":"61","author":"Liekens","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/70928","article-title":"Clinical applications for angiogenic growth factors and their inhibitors","volume":"5","author":"Ferrara","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","article-title":"Angiogenesis: implications for rheumatoid arthritis","volume":"41","author":"Koch","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-2143(98)90106-8","article-title":"Angiogenesis, a target for tumor therapy","volume":"132","author":"Griffioen","year":"1998","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.87.6.434","article-title":"Endothelial cell apoptosis in angiogenesis and vessel regression","volume":"87","author":"Dimmeler","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bmj.318.7187.853","article-title":"Antivascular therapy: a new approach to cancer treatment","volume":"318","author":"Hayes","year":"1999","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0958-1669(99)00024-5","article-title":"Current biology of VEGF-B and VEGF-C","volume":"10","author":"Olofsson","year":"1999","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0958-1669(99)00032-4","article-title":"VEGF and therapeutic opportunities in cardiovascular diseases","volume":"10","author":"Schaper","year":"1999","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0958-1669(00)00153-1","article-title":"VEGF: an update on biological and therapeutic aspects","volume":"11","author":"Ferrara","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s000110050743","article-title":"Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis\u2014targetting gelatinase A activation","volume":"50","author":"Jackson","year":"2001","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1440-1827.2002.01320.x","article-title":"Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration","volume":"52","author":"Kataoka","year":"2002","journal-title":"Path IT"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jcp.1041570319","article-title":"Activation of the 92 kDa type IV collagenase by tissue kallikrein","volume":"157","author":"Desrivieres","year":"1993","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/978-1-4615-9543-4_84","article-title":"Tissue kallikrein effectively activates latent matrix degrading metalloenzymes","volume":"247A","author":"Tscheche","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB23","first-page":"1103","article-title":"Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells","volume":"281","author":"Plendl","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0167-4889(02)00393-2","article-title":"Tissue kallikrein is synthesized and secreted by human vascular endothelial cells","volume":"1593","author":"Yayama","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0162-3109(99)00135-6","article-title":"Correlation of kinin-generating activity with Helicobacter pylori-associated gastric infection","volume":"43","author":"Naidoo","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB26","first-page":"1","article-title":"Bioregulation of kinins: kallikreins, kininogens and kininases","volume":"44","author":"Bhoola","year":"1992","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0162-3109(97)00031-3","article-title":"The evaluation of tissue kallikrein in Helicobacter pylori-associated gastric ulcer disease","volume":"36","author":"Naidoo","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB28","first-page":"1","article-title":"Kallikreins (kininogenases)\u2014a group of serine proteases with bioregulatory actions","volume":"31","author":"Schacter","year":"1980","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1113\/jphysiol.1960.sp006548","article-title":"Actions of pure bradykinin","volume":"153","author":"Elliot","year":"1960","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB30","series-title":"Kininogenases, Kallikrein","author":"Rixon","year":"1973"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01202732","article-title":"Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas","volume":"121","author":"Rehbock","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0162-3109(99)00101-0","article-title":"Tissue kallikrein and kinin receptors in oesophageal carcinoma","volume":"43","author":"Dlamini","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1240327","article-title":"Characterization of a tissue kallikrein in human prolactin-secreting adenomas","volume":"124","author":"Jones","year":"1990","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0162-3109(99)00097-1","article-title":"Kinin receptors are expressed in human astrocytic tumour cells","volume":"43","author":"Raidoo","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB35","first-page":"5046","article-title":"Multiple secretion of serine proteinases by human gastric carcinoma cell lines","volume":"52","author":"Koshikawa","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB36","first-page":"G854","article-title":"Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats","volume":"275","author":"Stadnicki","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1023\/A:1022569623350","article-title":"Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease","volume":"48","author":"Stadnicki","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB38","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2002-01-0185","article-title":"Kallistatin is a new inhibitor of angiogenesis and tumour growth","volume":"100","author":"Miao","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB39","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0002-9440(10)63026-X","article-title":"A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness","volume":"159","author":"Wolf","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB40","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI119669","article-title":"Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor","volume":"100","author":"Colman","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1083\/jcb.116.2.465","article-title":"Inhibition of cell adhesion by high molecular weight kininogen","volume":"116","author":"Asakura","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V95.2.543","article-title":"Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis","volume":"95","author":"Colman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB43","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1096\/fj.99-1025com","article-title":"Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5","volume":"14","author":"Zhang","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1538-7836.2003.00025.x","article-title":"Inhibition of angiogenesis by antibody blocking the action of proangiogenic high molecular weight kininogen","volume":"1","author":"Colman","year":"2003","journal-title":"J. Thromb. Haem."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB45","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1073\/pnas.192668299","article-title":"The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin","volume":"99","author":"Zhang","year":"2002","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2003.12.007_BIB46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0962-8924(98)01362-2","article-title":"ECM signalling: orchestrating cell behaviour and misbehaviour","volume":"8","author":"Lukashev","year":"1998","journal-title":"Trends Cell Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488903002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488903002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T15:18:53Z","timestamp":1585581533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488903002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":46,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0167488903002118"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2003.12.007","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}